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Abstract
Dupuytren´s disease, a fibromatosis of the connective tissue in the palm, is a common com-
plex disease with a strong genetic component. Up to date nine genetic loci have been found
to be associated with the disease. Six of these loci contain genes that code for Wnt signal-
ling proteins. In spite of this striking first insight into the genetic factors in Dupuytren´s dis-
ease, much of the inherited risk in Dupuytren´s disease still needs to be discovered. The
already identified loci jointly explain ~1% of the heritability in this disease. To further eluci-
date the genetic basis of Dupuytren´s disease, we performed a genome-wide meta-analysis
combining three genome-wide association study (GWAS) data sets, comprising 1,580
cases and 4,480 controls. We corroborated all nine previously identified loci, six of these
with genome-wide significance (p-value < 5x10-8). In addition, we identified 14 new sugges-
tive loci (p-value < 10−5). Intriguingly, several of these new loci contain genes associated
with Wnt signalling and therefore represent excellent candidates for replication. Next, we
compared whole-transcriptome data between patient- and control-derived tissue samples
and found the Wnt/β-catenin pathway to be the top deregulated pathway in patient samples.
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We then conducted network and pathway analyses in order to identify protein networks that
are enriched for genes highlighted in the GWASmeta-analysis and expression data sets.
We found further evidence that the Wnt signalling pathways in conjunction with other path-
ways may play a critical role in Dupuytren´s disease.
Introduction
Dupuytren’s disease (DD; OMIM 126900) is among the most common genetic diseases of con-
nective tissues. DD is a fibroproliferative disorder that affects the palmar aponeurosis and the
cutaneous retinacula of the hand. It manifests first through the formation of subcutaneous
nodules, fibrotic cords are found afterwards, and flexion contractures of single fingers can then
occur. There is no known cure for the disease. Surgical intervention is the most common treat-
ment option when hand function becomes hampered. The prevalence of DD has been esti-
mated as around 4% in England [1] and 2.5% in Germany [2]. It increases significantly with
age [3, 4] and was determined as 22% in a cross-sectional study of the population aged over 50
years in the northern part of the Netherlands [5] and 30% in the Norwegian population over
60 years of age [6]. Histopathologically, an increased proliferation of fibroblasts and differenti-
ation into myofibroblasts can be associated with a massive deposition of extracellular matrix
(ECM). The disease shows a progressive clinical behaviour with frequent local recurrence.
The causes for DD are multifactorial. Several environmental factors have been proposed to
contribute to DD development. Smoking and alcohol consumption have been associated with
DD [7–9]. Elevated blood glucose levels, low body weight, and low body mass index (BMI)
have also been shown to contribute to DD [9]. Heavy manual labour and exposure to vibra-
tions probably trigger the manifestation of the disease [10, 11]. Importantly, DD has a strong
genetic basis. Frequent familial occurrence is observed [12]. Studies have determined a family
predisposition in 12.5% [2] and 27% [13] of cases, respectively. The sibling recurrence risk λs
has been estimated to equal 2.9 based on a prevalence of 3.5% in northwestern England [14].
Patients with known family history show a trend to undergo surgery earlier than patients with-
out known family history [15]. DD has a polygenic basis, where different genetic risk loci
strongly contribute to disease susceptibility [16]. In a recent population-based twin study the
heritability of DD was calculated to be 80% [17].
The first GWAS for this disease [18] identified nine genome-wide significant loci. Six of
these loci contain genes known to be involved in Wnt signalling, namelyWNT4, SFRP4,
WNT2, SULF1, RSPO2, andWNT7B. Notably, these six genes are either Wnt ligands or extra-
cellular modulators of Wnt signalling, and therefore lie upstream of the Wnt signalling cascade.
This finding was the first insight that Wnt signalling may be one of the molecular mechanisms
that underlie the genetics of DD. The Wnt signalling pathway plays an important role during
embryogenesis and is tightly regulated on multiple levels [19]. Considering the late age of onset
in DD, which peaks in the 5th decade of life [5, 15], highly damaging mutations in Wnt or
other genes are not expected in DD. Accordingly, the majority of SNPs associated with com-
plex diseases map to non-coding regions, and it has been suggested that regulatory effects com-
monly underlie these GWAS signals [20]. Many of these regulatory effects will be small and
difficult to detect individually [21]. On top of that, GWAS for complex diseases usually point
to only a proportion of the causal genetic basis of the respective diseases and many signals
attributed to causal genetic variants may be hidden in the statistical noise of those GWAS. A
systems approach to analyse the pathways and networks involved in DDmay overcome at least
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partially these limitations. Network modelling can help to increase the statistical power to
detect susceptibility loci with more subtle effects by including candidate loci and modeling rela-
tionships between these loci and previously known, significantly associated loci derived from
GWAS. Network modelling is used extensively for gene expression data analysis, and a consen-
sus network interfered from mutable methods was shown to perform best [22].
To identify new loci associated with DD and corroborate the nine previously described
GWAS loci we performed a meta-analysis on the imputed genotypes of three genome-wide
GWAS data sets comprising 1,580 cases and 4,480 controls. As a first step in a systems genetics
approach to understand the pathogenesis of DD, we have integrated the GWAS results with
whole-transcriptome data. In a network analysis based on protein-protein interaction data we
identified functional modules of genes/proteins with shared characteristics that were overrep-
resented in our DD case/control data sets.
Methods
Study participants
The study was approved by the Ethics Commission of the Faculty of Medicine of the University
of Cologne and participants provided written informed consent. All participating subjects were
of European origin (see S1 and S3 Tables for details). The German study population is
described in detail elsewhere [15]. DNA was extracted from peripheral blood samples. RNA
was obtained from primary tissue samples from patients and sex and age matched controls.
Control connective tissue samples were obtained during trigger finger or carpal tunnel release.
Data sets
We included 1,580 cases and 4,480 controls in a meta-analysis on the imputed genotypes of
three genome-wide GWAS data sets (S1 Table). Samples were genotyped on three different
genotyping platforms. The first data set comprised 186 cases from Germany and Switzerland
typed on the Affymetrix Genome-Wide Human SNP Array 6.0 (809,858 SNPs) and 447 con-
trols typed on the same array from the KORA study (KORA [Cooperative Health Research in
the Region of Augsburg], Helmholtz Center Munich). The second data set consisted of 538
German and Swiss cases and 1197 controls from the Popgen study (Popgen, University of Kiel)
genotyped for 587,326 markers on the Affymetrix Axiom Genome-Wide CEU 1 Array. The
third data set comprised 856 cases (University Medical Center Groningen) and 2,836 controls
(LifeLines) genotyped for 234,758 markers on the Illumina HumanCytoSNP-12. This data set
was the discovery data set from Dolmans et al. [18], the first described GWAS for DD. The
other two data sets were partly used for replication of 34 discovery SNPs [18] but not analysed
for genome-wide association before. We performed sample imputation and phenotypic associ-
ation testing separately for each of the three platforms. Subsequently, the data from the three
GWAS were combined in a genome-wide meta-analysis. See also S1 Fig for an overview of the
study design.
Quality control
The same quality control parameters were applied separately to each data set. Following Dol-
mans et al. [18], we only considered bi-allelic non-ambiguous SNPs on autosomes and
excluded those with a marker call rate<95%, a minor allele frequency<1% or evidence for
deviations from Hardy Weinberg equilibrium in controls (p< 10−4). Moreover, we removed
samples with a call rate<99%, excess homo- or heterozygosity, an ambiguous sex assignment
or indication of being an outlier with respect to the genetic composition of the other samples.
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In addition, for pairs of duplicates or close relatives (average allele sharing identical-by-descent
>0.4), the sample with the lower call rate was excluded. The final data sets for analysis com-
prised 619 (180 cases, 439 controls), 1,530 (441, 1,089) and 3,654 (852, 2,802) samples,
respectively.
Pre-Phasing and imputation
We used SHAPEIT v.2.r790 [23] (https://mathgen.stats.ox.ac.uk/genetics_software/shapeit/
shapeit.html#download) for phasing genotype data prior to imputation. Genotype imputation
was done with IMPUTE2 v2.3.1 [24] (https://mathgen.stats.ox.ac.uk/impute/impute_v2.
html#download). We used reference data from the 1000 Genomes Project [25] (release of June
2014; https://mathgen.stats.ox.ac.uk/impute/data_download_1000G_phase1_integrated_
SHAPEIT2_16-06-14.html) for both phasing and imputation. Post-imputation quality control
required SNPs to have a minor allele frequency of at least 5% and an information score in the
imputation of at least 30%.
Genome-wide association testing
We used SNPTEST v2.5 [26] (https://mathgen.stats.ox.ac.uk/genetics_software/snptest/
snptest.html) for phenotypic association testing under an additive genetic model, using the pre-
dicted allele dosage from the imputation. Top-ranking components obtained from a multi-
dimensional scaling (MDS) analysis based on genome-wide data of allele sharing identical-by-
state were included as fixed effects in the regression-based association test in order to adjust for
population stratification. The number of MDS components was determined by minimizing
genomic inflation factor (see S1 Table).
Meta-analysis
We performed the genome-wide meta-analysis using GWAMA v2.1 [27] (http://www.well.ox.
ac.uk/gwama/index.shtml). The analysis was restricted to bi-allelic markers that had been stud-
ied for an association with DD in at least two cohorts (n = 5,894,478 SNPs). Effect sizes were
synthesized using a fixed-effects regression model, thereby hypothesizing that the studies dif-
fered only in their statistical power to detect the outcome of interest. Both Cochran’s Q statistic
and I2 index were used to evaluate statistical heterogeneity between studies [28].
Only SNPs that passed imputation post-hoc quality control and that were studied for an
association with Dupuytren’s disease in at least two cohorts were considered in the meta-analy-
sis (n = 5,894,478). SNPs for which Cochran’s Q test (p< 0.05) or the I² index (I²> 25) indi-
cated heterogeneity between studies were excluded (n = 1,543,737). In particular, the global
Manhattan plot and QQ plot, both generated via R-script provided by GWAMA, were finally
based upon 4,350,741 SNPs. 4,199,404 associations were studied in all three cohorts (96.52%).
Gene and pathway analysis
Search for overrepresented GO terms using Alligator. ALLIGATOR [29] (http://x004.
psycm.uwcm.ac.uk/~peter) was used to test for Gene Ontology (GO) categories that were over-
represented in a list of significantly associated SNPs from the meta-analysis. More specifically,
out of 4,350,741 SNPs that indicated no heterogeneity between studies, those 185,986 SNPs
that were nominally significant (p<0.05) and showed the same effect direction in all three stud-
ies were considered for the pathway enrichment analysis. Alligator assigns SNPs to genes based
on genomic location. More specifically, a SNP is assigned to a gene if it falls within the gene
plus 20kb upstream or downstream of the first and last exon.
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Gene-based test using VEGAS2. The offline version of VEGAS2 [30] () was used to
obtain gene-based p-values from single-SNP p-values. Based on SNP association p-values the
software calculates empirical gene-based p-values by a simulation procedure. We based our
analysis on those 4,350,741 SNPs that did not show indication of heterogeneity between stud-
ies. Estimation of inter-marker linkage disequilibrium was based on the EUR population from
the 1000 Genomes Project phase I. Gene boundaries were set to ±50 kb of each gene. Up to 106
simulations were performed per gene. 24,596 genes were tested and genes with p< 2.03x10-6
(Bonferroni correction for multiple testing, i. e. 0.05/24,596) were considered to be significantly
associated with DD.
Connecting genes from associated loci. We used three different software tools to search
for relationships between genes from those genetic loci that harbored at least one index SNP
with p< 10−5 in our meta-analysis:
GRAIL [31] (https://www.broadinstitute.org/mpg/grail/) looks for co-citations of genes
from the associated regions in scientific publications. Since GRAIL uses the hg18 genome
assembly and CEU HapMap SNPs, genomic regions instead of SNPs were used as query input
because most top-ranking SNPs from the meta-analysis were not present in HapMap. Regions
+/-50kb around the top-ranking SNP of each region were used as query regions. Chromosomal
positions were translated to hg18 coordinates with the UCSC LiftOver tool (http://genome.
ucsc.edu/cgi-bin/hgLiftOver) and used as query/seed regions for GRAIL analysis.
DAPPLE2 [32] (http://www.broadinstitute.org/mpg/dapple/dappleTMP.php) searches for
connections between query genes in a high confidence protein-protein interaction (PPI) data-
set (InWeb). We used SNPs, genomic regions, and genes as queries. Direct and indirect con-
nections are given by the software and parameters calculated by random permutation to access
the significance of the found connections.
In PrixFixe [33] (http://llama.mshri.on.ca/~mtasan/GranPrixFixe/html/) SNPs reported by
GWAS act as seeds for LD-based query regions. We assessed connections between genes based
on shared function using PrixFixe. Functional similarities between genes across distinct candi-
date sets were then located and genes scored based on the frequency and strength of identifying
such functional connections.
Network-based pathway analysis. We performed a network-assisted search for enriched
protein-protein interactions (PPIs) based on all gene-based p-values from the VEGAS2 analy-
sis. We used two different software tools for this approach, namely dmGWAS in R and Cytos-
cape (see below). For both tools, we used the 2014 version of the Reactome FI (http://www.
reactome.org/) as PPI reference dataset. This dataset contains 11,879 nodes and 217,249 edges
and is by design enriched for true biologically functional relationships [34].
The R package dmGWAS 3.0 [35] (http://bioinfo.mc.vanderbilt.edu/dmGWAS) was used
to search for enriched modules in Dupuytren´s disease using gene-based p-values as node
weights and differential co-expression of genes as edge weights (based on the whole transcrip-
tome data set). The EW_dmGWAS algorithm implemented in dmGWAS 3.0 integrates
GWAS signals and gene expression profiles to extract dense modules from the background PPI
network. Node weights are derived from GWAS gene-based p-values and edge weights are
derived from gene expression profiling. The resulting module score is a combination of node
weight and edge weight.
PINBPA [36] Cytoscape (http://www.cytoscape.org/) also searches for PPI in GWAS data-
sets. Genes with a p-value< 0.05, 0.1 and 0.2 were used as seed genes for a greedy search algo-
rithm-based search for connected modules. Genes from the gene-based test (VEGAS2) were
mapped to the Reactome FI network. All mapped genes with a p-value< 0.05 (or 0.1 and 0.2,
respectively) were used as seed genes in the greedy search for enriched modules. We considered
modules with a z-score> 5 and a network-size 5.
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Transcriptome analysis
The Illumina HumanHT-12 v3 Expression BeadChip was used for whole genome expression
analysis of disease samples and controls. Twelve primary tissue samples from patients were
compared with 12 sex and age matched controls. Total RNA was extracted from 150mg
RNAlater stabilised tissue by phenol/chloroform extraction. The tissue was cut into very
small pieces and homogenised in a beadmill (Tissue Lyser 2, Qiagen, Germany) for 2–6 min
at 30s-1 and room temperature. The phenol/chloroform purified RNA was precipitated with
ethanol; dried and resuspended in RNase free water. RNA concentration and integrity were
assessed with a 2100 Bioanalyzer (Agilent, Germany). For the whole-genome gene expres-
sion analysis only RNA samples with RNA integrity number (RIN)  6.9 were used. The
Illumina TotalPrep RNA Amplification Kit (Ambion, USA) was applied for generating bio-
tinylated, amplified RNA for hybridisation and samples were hybridised with the Illumina
HumanHT-12 v3 Expression BeadChip according to the manufactures’ protocol. Data were
analysed with the Illumina GenomeStudio Data Analysis Software and normalised, the
background was subtracted, the Illumina custom error model applied and p-values were
adjusted for multiple testing (Benjamini-Hochberg correction). Ingenuity Pathways Analy-
sis (IPA) software was used to identify altered pathways and protein networks in DD. Micro-
array data were submitted to the Gene Expression Omnibus (GEO) database (accession
number: GSE75152).
Results
GWASmeta-analysis in DD
Here we performed genome-wide genotype imputation and meta-analysis for three GWAS
data sets for DD, which comprise 5,803 samples after quality control, from Germany, Switzer-
land, and the Netherlands (S1 Fig). Manhattan and QQ plots were generated based on those
4,350,741 SNPs from the meta-analysis that did not indicate heterogeneity between studies
(Fig 1). In the subsequent analysis only SNPs that showed the same direction of effect in all
three data sets were considered (n = 4,199,404 SNPs) (S2 Table). Overall, the meta-analysis
yielded 910 SNPs showing suggestive association with DD (p<10−5), located in 23 chromo-
somal regions. Out of these, 371 SNPs reached genome-wide significance (p<5×10−8). These
SNPs are located on chromosomes 7p14.1 (n = 162), 8q13.2 (n = 79), 8q23.1 (n = 29), 9p24.3
(n = 25), 19q13.43 (n = 6), and 22q13.31 (n = 70). The top-ranking SNP from each of these loci
is given in Table 1. We confirmed six of the nine loci previously shown to be associated with
DD [18] on a genome-wide significant level. As in Dolmans et al. [18], we observed the stron-
gest association signal on chromosome 7p14.1. Here the imputed SNP rs17171229
(p = 1.11x10-28, OR 2.02) gave a slightly stronger signal in the meta-analysis than the previous
GWAS top SNP, rs16879765 (p = 1.52x10-27, OR 2.02). SNPs rs17171229 and rs16879765 are
in close linkage disequilibrium (r2 = 0.93; based on 1000 Genomes Project EUR phase 1 popu-
lation). For one locus that previously showed genome-wide significance, on chromosome
20q12, the top SNP in our meta-analysis, rs3577 located in the 5’UTR ofMAFB reached a p-
value of 1.12x10-7. We did not observe suggestive association signals for two previously
genome-wide significant loci, on chromosomes 1p36.12 (includingWNT4) and 7q31.2
(WNT2). On chromosome 1p36.12, rs7524102 associated with DD in Dolmans et al. [18],
showed a p-value of 4.88x10-5 (OR 1.28). The SNP with the lowest p-value in this region was
rs7537281 (p = 1.48x10-5; OR 1.30). SNP rs4730775 (withinWNT2) on chromosome 7q31.2
showed a p-value of 0.000791 (OR 0.85). The SNP with the lowest p-value in this region was
rs56145820 (p = 5.81x10-5; OR 1.28).
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Of the remaining 16 regions that contained SNPs with p-values<10−5 two have been previ-
ously identified: one on chromosome 6q25.1 near TAB2 (rs11155615, top-ranking SNP from the
meta-analysis, located intronic of UST), and the other one on chromosome 15q26.1 with the top-
ranking SNP from the meta-analysis, rs4932195, located between the genes ISG20 and ACAN.
Moreover, we identified 14 new suggestive loci on chromosomes 1q32.1, 2q24.3, 3p14.3, 4q12,
8p21.2, 9q22.32, 10p15.1, 10q23.1, 10q26.3, 11q22.3, 15q22.31-q23, 15q25.3-q26 and 16p13.3 (2
hits) with p<10−5 (Table 1). These loci require replication in an independent sample set.
Search for connections between potentially associated loci
In total, we identified 23 loci with suggestive evidence for association with DD. All these were
used for pathway analysis with GRAIL, DAPPLE2 and PrixFixe to identify the most likely can-
didate gene(s) from each region based on connectivity. The candidate gene(s) with the best
scores/lowest p-values for each region are given in Table 2. In order to allow comparison,
Table 2 also contains the gene(s) with the lowest p-values for each region from the VEGAS2
analysis. All three software tools unanimously identified SFRP4, KDR andWNT7B as the best
candidate genes in their respective loci. SFRP4 andWNT7B locate to the two regions with the
lowest p-values in our study. For one region, on 10q23.1 (rs10786118), no candidate genes
were identified by any software tool. Most interestingly, additional Wnt signalling components
were identified in regions with suggestive p-values, among themWNT5A on chromosome
5p14.3 and AXIN1 on chromosome 16p13.3. AXIN1 locates to a gene rich region with more
than thirty potential candidate genes.
GRAIL identified one or more candidate genes for 17 out of 23 regions, with four genes,
SFRP4,WNT7B, AXIN1 and RSPO2, having corrected p-values<0.01. When using candidate
SNPs as input, DAPPLE2 identified genes in 10 out of 23 regions. Connectivity among these
genes was not higher than expected by chance (and no single gene with p-values< 0.05).
When regions +/-50kb around the top-ranking SNP were used as input/seeds in the DAPPLE2
analysis (similar to GRAIL input), DAPPLE2 considered 13 out of 23 regions in the analysis
and identified two direct connections, betweenWNT7B and SFRP4 and between SMAD3 and
Fig 1. Results of the Genome-Wide Meta-Analysis in Dupuytren’s Disease. P-values were obtained
under an additive genetic model with adjustment for minor population stratification. Effect sizes were
synthesized using a fixed-effects regression model, thereby hypothesizing that the studies differed only in
their statistical power to detect the outcome of interest. Both Cochran’sQ statistic and I2 index were used to
evaluate statistical heterogeneity between studies. (A) Quantile-quantile (QQ) plot of observed phenotypic
association p-values. The grey line represents concurrence of the expected and the observed p-values under
a true null hypothesis of no association. Values above the line indicate a signal in the data. (B) Manhattan plot
showing the p-values (−log10) plotted against their respective positions on each chromosome with each dot
representing a SNP. Green dots represent SNPs that surpass the genome-wide significance threshold of
5×10−8. Manhattan and QQ plots were generated based on those 4,350,741 SNPs included in the meta-
analysis that did not show indication of heterogeneity between studies.
doi:10.1371/journal.pone.0158101.g001
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AXIN1. Again, the identified genes were not more connected than expected by chance (i. e. no
significant p-values for overall connectivity and for single candidate genes). PrixFixe identified
candidate genes in 19 regions. The software does not give p-values but a normalised scores
between 0 and 1, where a higher score indicates higher connectivity. Three genes,WNT5A,
SULF1 and TAB2, were uniquely identified by PrixFixe.
Functional annotation for all 13 non-redundant genes with p-values<0.01 or scores>0.4
with DAVID [37] resulted in the best enrichment cluster (enrichment score 4.1) for Wnt sig-
nalling (GO term GO:0016055, p-value 0.002 (Bonferroni corrected), KEGG pathway
hsa04310, p-value 7.56x10-4, SP-PIR keyword “wnt signaling pathway”, p-value 4.76x10-5) and
included five genes,WNT5A,WNT7B, SFRP4, RSPO2 and AXIN1.
Search for connections between GWAS loci
While we first restricted our search for functionally connected genes to the 23 regions showing
at least suggestive association in our meta-analysis, we subsequently used the software tool Alli-
gator to identify overrepresented GO terms in the whole meta-analysis data set. For 141 out of
2,631 analysed GO categories, the category-specific p-value for overrepresentation was<0.05
when using a cutoff of p<0.01 for defining significant SNPs (S4 Table). The number of all func-
tional types of GO categories (i.e. cellular components, molecular functions, and biological
Table 1. Top Ranking SNPs of the Genome-Wide Meta-Analysis in Dupuytren’s Disease.
SNP Chr Position A1/A2 OR p-value Direction of effect Gene(s) Reference
rs896319 1 205205651 G/T 0.71 1.08x10-6 — DSTYK, CNTN2 this report
rs12612573 2 167345393 C/G 1.26 3.86x10-6 +++ SCN9A this report
rs12493910 3 55909752 A/T 1.31 3.14x10-6 +++ ERC2, WNT5A this report
rs59885791 4 55943950 G/A 0.67 3.06x10-7 — KDR this report
rs11155615 6 149361706 A/G 1.28 1.57x10-6 +++ TAB2, UST, SUMO4 Dolmansa
rs17171229 7 37996682 T/C 2.02 1.11x10-28 +++ SFRP4, EPDR1 Dolmansa
rs1485748 8 25870252 A/G 1.27 1.76x10-6 +++ DPYSL2, EBF2 this report
rs13279808 8 69992479 G/T 1.36 1.02x10-10 +++ SULF1 Dolmansa
rs422847 8 109103274 A/G 0.76 9.29x10-9 — EIF3E, RSPO2 Dolmansa
rs183228744 8 145501808 A/G 0.77 7.85x10-6 — BOP1 this report
rs7867335 9 1200400 T/C 1.39 6.24x10-9 +++ DMRT2 Dolmansa
rs28436028 9 97426576 A/G 1.43 3.58x10-6 +++ C9orf3, FBP1 this report
rs138852017 10 4068310 G/A 1.51 8.04x10-6 +++ KLF6 this report
rs10786118 10 82663861 T/C 0.80 2.35x10-6 — TSPAN14, FAM213A, SH2D4B this report
rs61862987 10 132907934 A/G 1.39 3.71x10-6 +++ TCERG1L this report
rs661148 11 105700326 C/A 1.38 1.78x10-6 +++ CARD18, GRIA4, U4 this report
rs12899214 15 67302803 G/A 1.23 9.02x10-6 +++ SMAD3 this report
rs4932195 15 89252781 T/C 0.73 1.02x10-7 — ACAN, ISG20 Dolmansa
rs7189020 16 304803 A/T 1.25 7.03x10-6 +++ AXIN1, STUB1 this report
rs184572725 16 1305097 G/T 1.55 6.26x10-6 +++ TPSD1 this report
rs60333289 19 57677926 G/T 1.43 1.37x10-10 +++ AURKC, DUXA Dolmansa
rs3577 20 39314670 G/A 0.68 1.12x10-7 — PLCG1, MAFB Dolmansa
rs28502139 22 46396538 C/T 1.65 1.75x10-16 +++ WNT7B Dolmansa
p-values that surpass the level of genome-wide signiﬁcance are depicted in bold.
A1 –reference allele; A2 –alternative allele; OR–odds ratio
a Dolmans et al. [18]
doi:10.1371/journal.pone.0158101.t001
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processes) that reached significance levels for overrepresentation of 0.05, 0.01, and 0.001 are
shown in S5 Table.
Significance of the number of overrepresented categories was observed when using less strin-
gent p-values for defining significant SNPs (i.e. p<0.05 or p<0.01). This suggests that the genetic
susceptibility to DDmay involve risk alleles with rather small individual effects. In addition,
excess of overrepresented categories was most significant when using 0.01 as the significance cri-
terion defining overrepresentation. Associations for DD are thus supposed to be concentrated in
a moderate number of categories, with each of them showing strong evidence of overrepresenta-
tion. The three highest ranking overrepresented pathways were “positive regulation of cellular
protein metabolic process” (GO:0032270, p-value 0), “positive regulation of protein metabolic
process” (GO:0051247, p-value 0) and “response to drug” (GO:0042493, p-value 2x10-4).
Gene-based analysis
We used VEGAS2 to obtain gene-based p-values for phenotypic association from SNP-based
p-values, using the 1000 Genomes Project EUR phase 1 reference set. The gene with the lowest
p-value for each of the 23 candidate loci is given in Table 2. Overall, the gene-based test mirrors
the SNP-based GWAS results. For 14 genes the p-values exceeded a Bonferroni-corrected
threshold of p<2.03x10-6, including SFRP4, EPDR1 and NME8 on chromosome 7p14.1–14.2,
LINC01592 on chromosome 8q13.2, EIF3E on chromosome 8q23.1, ISG20 on 15q25.3–26.1,
ZNF246 on 19q13.43 andWNT7B, LOC730668, LINC00899, PRR34, PRR34-AS1,MIR-
LET7BHG, andMIR3619 on 22q13.31. Among these genes ISG20 is the only gene without adja-
cent genome-wide significant SNPs. However, a SNP near ISG20, rs4932194, showed
suggestive association with DD in Dolmans et al [18].
Differential gene expression and pathway analysis
Next we compared transcriptome levels in 12 primary disease tissue samples with that of 12
control tissue samples (S1 Fig). Cases and controls clearly clustered into two distinct groups
based on whole transcriptome expression patterns. We considered only transcripts with a
detection p-value of 0 in either one or both sample sets. 782 transcripts were upregulated with
a fold change2 (S6 Table) and 865 transcripts were downregulated with a fold change of-2
(S7 Table). Among the most upregulated transcripts with fold changes>10 (N = 75) were
extracellular matrix components including THBS4, TCN, COL11A1, COL13A1, POSTN, but
also other relevant genes such as TGFB2, ITGA10 andWISP1. Among the most downregulated
transcripts with a fold change<10 (N = 80) were genes related to muscle function/contraction,
notably ACTA1 and others. Considering the importance of Wnt signalling for the development
of DD, we specifically searched for differential expression of the genes involved. From all Wnt
genes covered by the array, however, onlyWNT2,WNT5B andWNT11 passed our quality cri-
teria.WNT2 showed no differential expression,WNT5B was 2.6-fold upregulated andWNT11
was 3.5-fold downregulated in DD cases.
Genes with a fold change cutoff of1.4 were further investigated in the IPA core analysis
(N = 4,062; S8–S12 Tables). The top canonical pathway was theWnt/β-catenin signalling pathway
(ratio 60/166 (0.361), p-value 1.57x10-6, z-score 0.302). A slightly positive z-score indicates upre-
gulation of this pathway in DD. The second highest ranking pathway was “LPS/IL-1 Mediated
Inhibition of RXR Function” (ratio 70/208 (0.337), p-value 4.40x10-6, z-score 1.80) and the third
highest ranking pathway was “Hepatic Fibrosis/Hepatic Stellate Cell Activation” (ratio 66/196
(0.337), p-value 7.97x10-6, z-score NA). The top network in the IPA analysis contained 68 nodes
and a score of 42, with the seed gene CTNNB1 encoding β-catenin. Functional annotation of
those 68 genes with DAVID and Enrichr [38] revealedWnt signalling as the best enriched
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signalling pathway for these genes. The top upstream regulator identified in the IPA core analysis
was TGFB1, predicted to be activated with a p-value of 4.96x10-13 and an activation z-score of
3.75. TGFB1 had 110 target molecules in the analyzed data set. The top biological function pre-
dicted to be activated with a z-score of 2.89 and a p-value of 4.81x10-25 was “proliferation of cells”.
Network-based pathway analysis
We further used two software tools for whole-genome pathway analysis, dmGWAS and the
cytoscape app iPINBPA. Both tools apply a greedy search algorithm to search for enriched
modules.
For dmGWAS we considered 24,596 genes with p-values and 3,873 genes with expression
values (fold change cutoff 1.4). The final background network had 2,165 nodes and 7,737
edges. The default lambda calculated by the software was 0.47. The analysis resulted in 943
modules with normalised module scores (Sn) between 18.91 and 0.76. We selected the top 5%
modules for further analysis to have sufficient numbers of genes for functional annotation clus-
tering. Within these 121 genes there were two genes from genomic regions with SNP-based p-
values<10−5,MAFB and ISG20. A full list of the genes is given in S7 Table. Functional annota-
tion for the 121 genes with DAVID [37] yielded 79 enrichment clusters. The best cluster had
an enrichment score of 6.76 and consisted of sixteen GO terms concerning fiber contraction
and the (actin) cytoskeleton. Other clusters concerned functions related to contraction, integ-
rin, adhesion, and the ECM (S13 and S14 Tables).
In contrast to dmGWAS, iPINBPA can restrict the overlap between modules resulting in
bigger top modules with a default of 20% maximal overlap. The top module (S15 Table) from
the iPINBPA analysis contained 851 nodes and had a z-score of 44.9. The start gene for this
module wasMYC. The mean gene-based p-value from the top modules was 0.12±0.08 and the
mean SNP-based p-value was 0.01±0.02. Five genes from the top GWAS meta-analysis regions
were included in this network, namely AXIN1, EIF3E, ISG20,MAFB, SFRP4, and RBBP5.
Functional annotation of the 851 genes with DAVID [37] resulted in 320 enrichment clus-
ters (S16 Table). The best enrichment cluster had a score of 26.77 and consisted of six cellular
component GO terms, all concerning nuclear lumen and nucleoplasm. Interestingly the 14th
best enrichment cluster, with a score of 5.74, concernedWnt signalling with the following 29
genes: NKD2,WNT5B, CAMK2G, PPP2R5C, TCF7L2, CTNNB1,WNT2, RAC1, PPP3CC,
FRAT2, PLCB1, AXIN2,MYC, FBXW11, AXIN1, DVL2, TBL1XR1, DVL3, ROCK2, CREBBP,
SMAD3, FZD7, CTNNBIP1, SENP2, CCND1, PRICKLE1, GSK3B, SFRP4, PPP2R5E. We also
analysed the list of 851 genes with the Enrichr [38] tool (S17 Table). Among the top ten path-
ways associated with the iPINBPA top module were Wnt signalling, Notch signalling and focal
adhesions. The overlap between the top 5% from dmGWAS and top module from iPINBPA
were 40 genes (p-value of overlap<4.2x10-17 based on 11,879 genes in the Reactome PPI data).
These 40 genes are shown in S11 Table. Among these genes were AXIN2, IGF1, ISG20, ITGB1,
LAMB1,MAFB and others. The mean gene-based p-value for these 40 genes was 0.086±0.073
and the mean SNP-based p-value was 0.005±0.006. These values are thus slightly smaller than
the mean p-values for the individual gene lists from dmGWAS and iPINBPA.
Discussion
We performed a genome-wide meta-analysis as well as enrichment and functional analysis for
Dupuytren’s disease (DD), based on three data sets comprising in total 1,580 cases and 4,480
control samples from Germany, Switzerland and the Netherlands. We only considered those
SNPs that showed the same direction of effect in all three data sets in order to increase the
robustness of our results, restricting the analysis to 4,199,404 SNPs in total. Because of the still
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relatively small sample size, we opted for including all samples in one meta-analysis and did
not split the samples into discovery and replication data sets. A weakness of this study is, thus,
the current lack of replication in an independent data set. Nevertheless, our approach of a
genome-wide meta-analysis after stringent quality procedure application in all data sets is likely
to have revealed robust findings of suggestive evidence for new susceptibility loci and impor-
tant insight into disease mechanisms involved in the pathogenesis of DD.
First, we have confirmed six of the nine previously described loci associated with DD on
genome-wide significance level in an enlarged data set. Second, we have identified 14 new sugges-
tive loci, with p-values ranging between 1x10-7 and 9x10-6. In any case, these loci require confir-
mation and replication in an independent data set. Intriguingly, however, several new loci of
suggestive evidence again contain genes related toWnt signalling. These genes includeWNT5A
on chromosome 3p14.3, which is a ligand of frizzled receptors; EBF2 on 8p21.2, which acts in
synergy with the Wnt-responsive LEF-1/β-catenin pathway; SMAD3 on 15q22.33, which is
involved in positive regulation of the canonical Wnt signalling pathway; and AXIN1 on 16p13.3,
which is a component of the β-catenin destruction complex. These observations clearly support
the notion that the suggestive loci identified in this study may be indeed true signals, they corrob-
orate the outstanding importance of Wnt signalling in the susceptibility for DD and meet the
expectation that Wnt signalling pathway related genes were also located in genomic regions with
weaker association signals. Our results provide evidence in addition to previous observations that
Wnt signalling is involved in the genetic basis of the disease.
The observed distribution of small p-values derivates early from the expected distribution as
seen in the QQ plot, both for the SNP-based and gene-based data. Even after stringent correc-
tion for genomic inflation (population stratification) a large number of SNPs (and genes) with
small p-values remain. Although data from a larger sample set strictly corrected for population
stratification are necessary to substantiate this observation regarding Dupuytren’s disease, a
broad genetic basis is common in truly complex genetic diseases [39, 40]. About 6% of all tested
genes had p-values<0.05 in the gene-based association test conducted with VEGAS2. This is
similar to the percentages reported recently, for instance, for three schizophrenia GWAS data
sets described by Chang et al [41]. Assuming many loci involved in the susceptibility for the
disease, genome-wide network analysis may help to identify true genetic associations with
small effect sizes in the increasing noise of false positives with larger p-values. Predicting the
importance of a functional module is often easier than that of single genes [42].
In this study, we have performed a comprehensive pathway and network analysis for DD
using data from GWASmeta-analysis mainly with two different software tools. Both tools use a
greedy search algorithm to search for densely connected modules that are enriched for small p-
values. We increased the power to detect functionally relevant PPI networks by integrating
GWAS with differential gene expression data. Indeed, our results indicate a broad functional
spectrum for the genetic basis of DD, covering many small effect size variants supposed to play a
role. It is apparent from our analysis that in addition to the Wnt signalling, other signalling path-
ways and biological processes, notably focal adhesions and Notch signalling, may play a role.
This is in concordance with the observations that complex diseases, with the probable exception
of immune diseases, may be genetically based on a number of different (signalling) pathways [43,
44]. TheWnt and Notch signalling pathways are both highly conserved, and heavy crosstalk is
known to take place between them during development and disease [45]. Knowledge of the inter-
play of different pathways will ultimately help to understand pathogenic mechanisms and design
treatment options for a disease [46]. Notably, functional annotation of gene lists is only the first
step to functional characterization especially in the context of disease and affected tissues.
In our network analysis many factors point to the importance of ECM and focal adhesion,
especially the results from dmGWAS, where the network analysis was based on GWAS and
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gene expression data. The expression of many ECM component genes was found to be upregu-
lated in DD tissues compared to control tissues in our and other studies [47–51]. This network
analysis may help to identify those ECM components deregulated in DD that are critically
influenced by genetic factors. Of note, some of the genes from the suggestive GWAS regions
code for ECM components or secreted proteins, such as ACAN and TPSD1.
Whole-transcriptome analysis correlated with the GWAS data results in that it highlighted
the Wnt signalling pathway to be differentially expressed in disease compared to control tissue.
Our transcriptome results support the GWAS findings, highlighting the canonical Wnt/β-cate-
nin pathway to be significantly altered in disease tissues compared to control tissues. Although
there are numerous expression studies published in DD [47–51] none of them reported upre-
gulation of Wnt/β-catenin signalling so far, though upregulation and the accumulation of
nuclear β-catenin levels in DD tissues have been described [52, 53]. Moreover, micro-RNA
profiling in DD showed deregulation of β-catenin in DD recently [54]. Other deregulated path-
ways concerned immune responses and fibrotic processes, which might fit well to the proposed
disease mechanisms. The observed downregulation ofWNT11 in patient tissues is in accor-
dance with previous findings [55].
Conclusion
We replicated for the first time previously identified susceptibility loci for DD in a meta-analy-
sis of three imputed GWAS data sets. Our findings further corroborate the strong genetic basis
and the wide importance of Wnt signalling genes in the susceptibility for DD. In addition, the
results demonstrate that genome-wide imputation increases the power of association studies
for finding new risk loci for DD. Moreover, we performed whole transcriptome analysis of DD
tissues compared with control tissues and found the Wnt signalling pathway significantly
deregulated in DD. In summary, our pathway and network analyses, integrating GWAS and
transcriptome data, indicate that DD may have a broad genetic basis. The pathogenesis
involves Wnt signalling and several other biological processes including the regulation of focal
adhesions and the deposition of the ECM.
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